Bank Of America Corp Cytokinetics Inc Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, Bank Of America Corp holds 4,380,769 shares of CYTK stock, worth $248 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,380,769
Previous 4,777,628
8.31%
Holding current value
$248 Million
Previous $335 Million
29.14%
% of portfolio
0.02%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$832 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$648 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$461 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$426 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$371 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.34B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...